Загрузка...
Cardiogenic Shock in a Hemodialyzed Patient on Flecainide: Treatment with Intravenous Fat Emulsion, Extracorporeal Cardiac Life Support, and CytoSorb® Hemoadsorption
A 67-year-old woman with a history of end-stage renal disease on hemodialysis received a therapeutic dose (150 mg daily) of flecainide for three weeks. She was admitted to the Emergency Department for malaise and dizziness, and the electrocardiogram revealed ventricular tachycardia treated by amioda...
Сохранить в:
| Опубликовано в: : | Case Rep Cardiol |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Hindawi
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6681578/ https://ncbi.nlm.nih.gov/pubmed/31428479 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/1905871 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|